Impact of metformin on patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.

Pei-Hung ChangKun-Yun YehCheng-Hsu WangEric Yen-Chao ChenShih-Wei YangWen-Chi ChouJason Chia-Hsun Hsieh

Published in: Head & neck (2017)

Patients with head and neck cancer undergoing concurrent CRT along with metformin treatment require more careful multidisciplinary assessment and supportive care to ensure successful completion of treatment and avoid treatment-related toxicities.

Keyphrases

healthcare
squamous cell carcinoma
palliative care
combination therapy
radiation therapy
atrial fibrillation
replacement therapy
pain management
smoking cessation